atropine has been researched along with Basal Ganglia Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansdak, SG; Mathew, V; Patil, AK; Peter, JV; Ralph, R; Reji, KK; Zachariah, A | 1 |
| Ghosh, S; Kundu, AK; Maisnam, I; Maity, A; Saha, SP; Tanima, D | 1 |
| Habaguchi, T; Ohtinata-Sugimoto, J; Saitoh, K; Sakamoto, T; Takakusaki, K | 1 |
| Fregnan, GB; Vidali, M | 1 |
| Asper, H; Bürki, HR; Ruch, W; Sayers, AC | 1 |
| Troch, E; Verheecke, G | 1 |
| Barkhatova, VP; Gotovtseva, EV; Ivanova-Smolenskaia, IA; Markova, ED; Tkachev, RA | 1 |
7 other study(ies) available for atropine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Extrapyramidal effects of acute organophosphate poisoning.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Atropine; Basal Ganglia Diseases; Critical Care; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Muscarinic Antagonists; Organophosphate Poisoning; Pneumonia, Ventilator-Associated; Prospective Studies; Respiration, Artificial; Treatment Outcome; Young Adult | 2016 |
Atypical central nervous system involvement in acute organophosphorous poisoning.
Topics: Adult; Antidotes; Atropine; Basal Ganglia Diseases; Brain; Dimethoate; Female; Humans; Insecticides; Muscarinic Antagonists; Organophosphate Poisoning; Pralidoxime Compounds; Tomography, X-Ray Computed | 2011 |
Basal ganglia efferents to the brainstem centers controlling postural muscle tone and locomotion: a new concept for understanding motor disorders in basal ganglia dysfunction.
Topics: Animals; Atropine; Basal Ganglia; Basal Ganglia Diseases; Bicuculline; Brain Stem; Cats; Choline O-Acetyltransferase; Disease Models, Animal; Efferent Pathways; Electric Stimulation; Electromyography; Evoked Potentials, Motor; Excitatory Amino Acid Agonists; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Kainic Acid; Locomotion; Muscarinic Antagonists; Muscimol; Muscle Tonus; N-Methylaspartate; Neural Inhibition; Picrotoxin; Stimulation, Chemical | 2003 |
Appearance of extrapyramidal symptoms: interaction between neuroleptics and other CNS active drugs.
Topics: Animals; Antipsychotic Agents; Atropine; Autonomic Agents; Basal Ganglia Diseases; Central Nervous System Agents; Female; Histamine H1 Antagonists; Motor Skills; Pilocarpine; Rats; Rats, Inbred Strains; Serotonin Antagonists | 1982 |
Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects.
Topics: Animals; Antipsychotic Agents; Atropine; Basal Ganglia Diseases; Clozapine; Corpus Striatum; Drug Interactions; Dyskinesia, Drug-Induced; Female; Haloperidol; Homovanillic Acid; Male; Parasympathetic Nervous System; Physostigmine; Rats; Receptors, Dopamine; Receptors, Muscarinic | 1976 |
Oral droperidol for premedication in children.
Topics: Administration, Oral; Adolescent; Akathisia, Drug-Induced; Atropine; Basal Ganglia Diseases; Child; Child, Preschool; Droperidol; Drug Combinations; Humans; Infant; Preanesthetic Medication; Salivation; Vomiting | 1985 |
[Principles of the pathogenetic therapy of congenital extrapyramidal diseases].
Topics: Adolescent; Adult; Atropine; Basal Ganglia Diseases; Chelating Agents; Chronic Disease; Dihydroxyphenylalanine; Female; Hepatolenticular Degeneration; Humans; Hyperkinesis; Male; Pantothenate Kinase-Associated Neurodegeneration; Parkinson Disease; Penicillamine; Phenothiazines; Pyridoxine; Sulfhydryl Compounds; Trifluoperazine; Tropanes | 1973 |